US Stock MarketDetailed Quotes

VKTX Viking Therapeutics

Watchlist
  • 42.250
  • +0.760+1.83%
Close Dec 20 16:00 ET
  • 42.850
  • +0.600+1.42%
Post 19:58 ET
4.71BMarket Cap-44.95P/E (TTM)

About Viking Therapeutics Company

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Company Profile

SymbolVKTX
Company NameViking Therapeutics
Listing DateApr 29, 2015
Issue Price8.00
Founded2012
CEODr. Brian Lian, PhD
MarketNASDAQ
Employees27
Fiscal Year Ends12-31
Address9920 Pacific Heights Boulevard,Suite 350
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-704-4660
Websitehttp://www.vikingtherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Brian Lian, PhD
  • President, Chief Executive Officer and Director
  • 12.63M
  • Marianne Mancini
  • Chief Operating Officer
  • 3.51M
  • Greg S. Zante
  • Chief Financial Officer and Principal Accounting Officer
  • 3.50M
  • Matthew W. Foehr
  • Independent Director
  • 169.37K
  • Charles A. Rowland, Jr,M.B.A.
  • Independent Director
  • 189.62K
  • Dr. S. Kathryn Rouan, PhD
  • Independent Director
  • 178.65K
  • J. Matthew Singleton
  • Independent Director
  • 192.77K
  • Dr. Lawson Macartney, D.V.M.,PhD
  • Chairperson of the Board
  • 222.72K
Heat List
US
Overall
Symbol
Price
% Chg

No Data

Investment Theme Weight Loss Drugs
Weight Loss Drugs
Intraday-4.61%